Trial NCT04901299

View at ClinicalTrials.gov 
Org. Study IDs: 21-038

Last trial update was posted on 2023-08-01

MeSH Interventions

Fulvestrant Neratinib

MeSH Conditions

Breast Neoplasms

Other Conditions

ER Positive Breast Cancer HER2-negative Breast Cancer Invasive Breast Cancer Metastatic Breast Cancer PR-Positive Breast Cancer Stage IV (Metastatic) Breast Cancer

Stopping Reasons

Team decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID